Chronic kidney patients. Chronic kidney disease, unspecified
Conditions
Interventions
Intervention 1: Based on the block of redundancy and the patient in the intervention group, 1 hour before biopsy, desmopressin acetate is received in the nose and 1 kg / kg. After 1 hour, the ultrasou
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: People 18 years and older 15=GFR=90 cc/min/1.73 m2 according MDRD formula
Exclusion criteria
Exclusion criteria: Disrupted coagulation profile (including disruption in any of the PT tests, INR, PTT, and platelet counts are less than 50000 Systrelic Blood Pressure Time Biopsy less than160mmhg Diastolic BP Time to do biopsy less than100mmhg Single kidney Kidney cancer Renal hydronephrosis Renal Pyrenophore Small size Significant kidneys in ultrasound Severe obesity Hemoglobin less than 11 Sodium concentration in serum less than 120 Primary phenotypes Renal transplantation Multiple cysts in both kidneys
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematoma. Timepoint: Immediately after receiving a kidney biopsy specimen and 24 hours later, and in the event of a hematoma, 48-72 hours later. Method of measurement: Ultrasonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hematuria. Timepoint: After biopsy. Method of measurement: View at any time urinating.;Vital signs l (blood pressure and heart rate). Timepoint: Every 15 minutes for 2 hours, then every 1 hour for 4 hours, then every 2 hours for 6 hours, and then every 4 hours. Method of measurement: Device.;Flank pain. Timepoint: Follow up on every visit. Method of measurement: Physical exam.;Biochemical Factors (Sodium, Hemoglobin, Hematocrit). Timepoint: 24 hours after biopsy. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Ghorbani
Ahvaz University of Medical Sciences
Outcome results
None listed